Mark Stolper

Mark D.
Stolper was the founder of Broadstream Capital Partners LLC, founded in 1999, where the title held was Partner.
Current jobs include Director at Rotech Healthcare, Inc. since 2016; Director at Surgalign Spine Technologies, Inc. since 2017; Director at American Addiction Centers, Inc.; Director at Rotech Healthcare Holdings, Inc. since 2016; Independent Director at The Oncology Institute, Inc. starting 2026; Chief Financial Officer & Executive Vice President at RadNet, Inc. since 2004; and Chief Financial Officer at iCAD, Inc. starting 2025.
Former jobs include Chairman at CompuMed, Inc. from 2009 to 2014; Director at ALCO Stores, Inc. from 2014 to 2015; Director at Tix Corp.
from 2011 to 2013; Independent Director at Metropolitan Health Networks, Inc. from 2010 to 2012; Director at GenesisCare USA, Inc.; Independent Director at On Track Innovations Ltd. from 2012 to 2016; Director at Physiotherapy Associates, Inc. from 2013 to 2016; Director at 21st Century Oncology Holdings, Inc. from 2018 to 2020; Independent Director at Coherus Oncology, Inc. from 2021 to 2025; Director at Surgical Solutions LLC from 2015 to 2017; Lead Independent Director at Surgalign Holdings, Inc. from 2020 to 2023; Chief Financial Officer at Primedex Health Systems, Inc.; Member at Dillon & Associates, Inc.; Member at Saratoga Management Co. LLC; Member-Corporate Finance Group at Dillon, Read & Co., Inc.; Member at Read & Co. Utility Services Ltd.; Member at Goldman Sachs Realty Management LLC from 1995 to 1998; Member at Archon Capital Management LLC from 1995 to 1999; and Partner at West Coast Capital from 2001 to 2004.
Education includes undergraduate degree from the University of Pennsylvania in 1993, graduate degree from the University of California, Los Angeles, and undergraduate degree from The Wharton School of the University of Pennsylvania.